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Mammalian PKD (protein kinase D) isoforms have been
implicated in the regulation of diverse biological processes
in response to diacylglycerol and PKC (protein kinase C)
signalling. To compare the functions of PKD1 and PKD2
in vivo, we generated mice deﬁcient in either PKD1 or PKD2 en-
zymatic activity, via homozygous expression of PKD1
S744A/S748A
or PKD2
S707A/S711A ‘knockin’ alleles. We also examined PKD2-
deﬁcient mice generated using ‘gene-trap’ technology. We
demonstrate that, unlike PKD1, PKD2 catalytic activity is
dispensable for normal embryogenesis. We also show that PKD2
is the major PKD isoform expressed in lymphoid tissues, but
that PKD2 catalytic activity is not essential for the development
of mature peripheral T- and B-lymphocytes. PKD2 catalytic
activity is, however, required for efﬁcient antigen receptor-
induced cytokine production in T-lymphocytes and for optimal
T-cell-dependent antibody responses in vivo. Our results reveal a
key in vivo role for PKD2 in regulating the function of mature
peripheral lymphocytes during adaptive immune responses. They
also conﬁrm the functional importance of PKC-mediated serine
phosphorylation of the PKD catalytic domain for PKD activation
and downstream signalling and reveal that different PKD family
members have unique and non-redundant roles in vivo.
Key words: cytokine, lymphocyte, protein kinase C (PKC),
protein kinase D (PKD), T-cell antigen receptor (TCR).
INTRODUCTION
The mammalian serine/threonine PKD (protein kinase D) family
comprises three different, but closely related, serine kinases,
PKD1, PKD2 and PKD3, all of which have a highly conserved
N-terminal regulatory domain containing two cysteine-rich
DAG (diacylglycerol)-binding domains and an autoinhibitory
PH (pleckstrin homology) domain. PKD family members are
activated by binding DAG to their regulatory domain and
by PKC (protein kinase C)-mediated phosphorylation of two
conserved serine residues in their catalytic domain in response
to phospholipase C and DAG signalling [1]. PKDs are highly
conservedenzymes,withPKD1andPKD2beingthemostclosely
related of the three mammalian PKD isoforms, showing ∼85%
overallidentityattheaminoacidlevel.Inparticular,theircatalytic
domains and their regulatory DAG-binding domains, which are
key for controlling the intracellular localization of these protein
kinases, are highly homologous. One consequence of the high
level of conservation of PKD1 and PKD2 is that it has been
difﬁcult to develop antibodies that can distinguish between these
isoforms, although there are antibodies that selectively recognize
PKD3. Accordingly, many studies of PKD function do not
specify which PKD isoform is being studied. This is important
as PKD1 and PKD2 share common regulatory mechanisms in
many cell types. For example, ectopically expressed GFP (green
ﬂuorescent protein)-tagged PKD1 and endogenous PKD2 show
identical mechanisms and kinetics of activation, inactivation and
subcellular trafﬁcking in response to antigen receptor triggering
in the leukaemic Jurkat T-cell line and in A20 lymphoma B-cells
[2,3].
Many adult tissues and cell lines show co-expression of
the different PKD isoforms, and it is evident that there can
be functional redundancy between these different PKD family
members. For example, birds express two PKD isoforms that
most closely resemble mammalian PKD1 and PKD3, and either
of these two kinases can phosphorylate and regulate the nuclear
export of the class II HDACs (histone deacetylases) HDAC5 and
HDAC7 in avian B-cells [4]. Similarly, multiple PKD isoforms
appear to redundantly regulate Golgi organization and protein
transport [5−9], NF-κB (nuclear factor κB) activation and cell-
survivalresponses[10−12],andchemokinereleasefromToll-like
receptor-activated epithelial cells [13]. Functional redundancy
between different PKD isoforms has also been observed for the
phosphorylation of PKD substrates such as CERT (ceramide-
transport protein) [14], PAR1b (partitioning defective 1) [15],
sphingosine kinase 2 [16] and HSP27 (heat-shock protein 27)
[17,18].
FunctionalredundancybetweendifferentPKDfamilymembers
expressed in the same tissues/cells is not always the case,
however. For example, PKD-mediated phosphorylation of
phosphoinositide 4-kinase IIIβ is regulated by PKD1 and PKD2,
but not by PKD3 [19]. In addition, there is differential timing of
expression of PKD isoforms during early murine embryogenesis
[20], and there are examples of cell types where expression
of a single PKD isoform appears to dominate. Consequently,
speciﬁc and non-redundant roles for PKD1 in regulating insulin
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secretion in pancreatic β-cells [21], TLR (Toll-like receptor)-
dependent cytokine expression in macrophages [22], keratinocyte
proliferation [23] and pathological cardiac remodelling in vivo
[24] have been identiﬁed.
Our understanding of the functions of the different mammalian
PKD isoforms is complicated further by the observation that
distinct PKD protein pools have been observed at different
intracellular sites, including the plasma membrane, cytoplasm,
Golgi, mitochondria and nucleus [25]. In addition, different
PKD isoforms can differentially localize within the same cell
[26]. PKDs have also been shown to trafﬁc between different
cellular locations in response to speciﬁc stimuli [2,3,27,28],
which has major consequences for the function of these enzymes.
Thus Golgi-localized PKD regulates phosphoinositide 4-kinase
IIIβ phosphorylation and vesicle trafﬁcking [19], whereas
mitochondrial PKD controls expression of SOD2 (superoxide
dismutase 2) via activation of NF-κB [29]. Similarly, plasma-
membrane-targeted and cytosolic PKD proteins regulate different
aspects of T-cell differentiation [30].
Collectively, these data argue for unique functions for
different PKD family members in different cellular contexts.
An effective way to probe the physiological role of individual
PKD isoforms is to look at the consequences of deleting the
individual enzymes using gene-targeting strategies in mice.
This approach has been used previously to probe the role
of PKD1, revealing that homozygous germline deletion of
PKD1causesembryoniclethality[24].Moreover,cardiomyocyte-
speciﬁc deletion of PKD1 has also identiﬁed a unique and non-
redundantroleforPKD1inpathologicalcardiacremodelling[24].
There has also been a mutant mouse strain described (129S5-
Prkd3
Gt(OST191038)Lex/Mmcd) that harbours a gene-trap deletion of
PKD3. The mice are reportedly viable, and phenotypic analysis
has revealed only a mild skeletal abnormality. To date, however,
there have been no studies that have explored the role of PKD2
in vivo, although there are several in vitro studies using RNAi
(RNA interference) techniques in cell lines that have proposed
important non-redundant functions for PKD2. These include a
keyroleforPKD2inendothelialcells,tocontrolcellproliferation
and survival and to promote angiogenesis [31], and in monocytes,
to control migratory responses [32]. Accordingly, the object of
the present study was to produce mouse models that would allow
an exploration of the role of PKD2 in physiological responses
during embryogenesis and in adult mice.
The data show that mice deﬁcient in PKD2 enzymatic activity
were born at normal Mendelian frequency and were fertile and
healthy. Strikingly, we observed that PKD2, but not PKD1, is
selectively expressed in lymphoid cells in adult mice, but that
the loss of PKD2 catalytic activity had no obvious effect on the
development of mature T- and B-lymphocytes. PKD2 catalytic
functionwas,however,importantforeffectorcytokineproduction
after TCR (T-cell antigen receptor) engagement and also for
optimal induction of antibody responses to a model antigen. The
datarevealthatPKD1,butnotPKD2,catalyticactivityisessential
for normal embryo development, and that PKD2, but not PKD1,
has an important role in adult mice to control the function of
lymphoid cells during adaptive immune responses.
MATERIALS AND METHODS
Generation of PKD2 and PKD1 transgenic mice
PKD2-knockin mice on a C57BL/6 background were generated
by Ozgene. Brieﬂy, genomic fragments containing exons 15−17
ofthePrkd2genewereampliﬁedbyPCRfromC57BL/6genomic
DNAtogenerate5
  and3
  homologyarmsthatwereusedtoﬂanka
loxP-PGK-Neo
R-LoxP selection cassette. Mutations (underlined)
within the 5
  homology arm that encoded alanine point mutations
of Ser
707 and Ser
711 (5
 -GAGAAGGCCTTCCGGCGCGCCGTG-
3
 ) were introduced by PCR. Forward and reverse DNA
sequencing and restriction enzyme digests conﬁrmed the
integrity of the ﬁnal targeting construct. Following homologous
recombination of the targeting vector in C57BL/6 ES (embryonic
stem) cells, correctly targeted clones were identiﬁed by Southern
blot analysis. The integrity of the Ser
707 and Ser
711 knockin
point mutations in the targeted ES cells was conﬁrmed by PCR
screening and DNA sequencing. Targeted ES cell clones were
microinjected into C57BL/6 blastocysts to generate chimaeric
animals. After establishment of germline transmission, the PGK-
Neo
R cassette was deleted by breeding to a transgenic line
containing Cre recombinase inserted into the Rosa26 locus (OZ
Cre deleter mice). Selective breeding was used to eliminate
the Cre gene and PKD2
SSAA (PKD2
S707A/S711A)-knockin mice
were maintained on a pure C57BL/6 genetic background.
Genotyping was carried out by PCR of genomic DNA using
primers671−5
 armF(5
 -AGTGGCACGTTCCCCTTCAATG-3
 )
and 671−3
 armR (5
 -CTTTGCCCAATCCCTTACAGCCT-3
 ),
producing products of 236 bp [PKD2
WT (wild-type PKD2)] and
344 bp (PKD2
SSAA).
A similar methodology was followed to generate PKD1
SSAA
(PKD1
S744A/S748A)-knockin mice, except that nucleotides encoding
Ser
744 and Ser
748 were mutated to alanine (5
 -GCCT-
TTAGGAGGGCC-3
 ). Genotyping was carried out by PCR
of genomic DNA using primers 579−5
 armF2 (5
  CAGCCT-
TCATGTATCCACCCAACC) and 579−3
 armR (5
  TGAACAA-
CAGCAGAGCCCTAACAG), producing products of 512 bp
(PKD1
WT) and 649 bp (PKD1
SSAA).
Generation of PKD2 gene-trap mutant mice
PKD2-deﬁcient mice were generated by a retrovirus-based gene-
trap technique. An E14Tg2a.4 ES cell line (derived from the
129/OlaHsdmousestrain)containingagene-trapcassetteinserted
into the Prkd2 locus (RRJ380, Bay Genomics) was injected
into C57Bl/6J blastocysts, which were subsequently implanted
into recipient female mice. The ES cells were subject to DNA
sequence analysis before microinjection to conﬁrm that the
cell line contained only a single gene-trap cassette, located
within the PKD2 locus. The resulting chimaeric mice were bred
into a C57BL/6 background to obtain germline transmission.
Genotyping was carried out by PCR of genomic DNA using
primers PKD2-GTF6 (5
 -GTTCCCCTTCCAGTCCATAATC-
CTCCT-3
 ), PKD2-GTR2 (5
 -CGATGATGCGAGCGAAGCCA-
AA-3
 ) and B-geo5
 R2 (5
 -TGCCAGTTTGAGGGGACGAC-
GACA-3
 ) in a single PCR, producing products of 498 bp
[PKD2
GT (PKD2 gene-trap)] and 441 bp (PKD2
WT). All
experiments on mice were conducted on a mixed 129-C57BL/6J
background.
Allmicewerebredandmaintainedunderspeciﬁcpathogen-free
conditions in the Wellcome Trust Biocentre at the University of
DundeeincompliancewithU.K.HomeOfﬁceAnimals(Scientiﬁc
Procedures) Act 1986 guidelines.
Cell culture
Spleens, thymi and lymph nodes were removed from 2−4-
month-old mice, mashed in cell strainers and disaggregated, and
red blood cells were lysed as required before the lymphocytes
were suspended in RPMI 1640 medium containing L-glutamine
(Invitrogen) with 10% (v/v) heat-inactivated FBS (fetal bovine
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serum),50 units/mlpenicillin,50 μg/mlstreptomycinand50 μM
2-mercaptoethanol.Thecellswereactivatedwith200 nMphorbol
12,13-dibutyrate, 2 μM OVA peptide (SIINFEKL) or the
indicated concentrations of anti-CD3ε antibody (clone 2C11),
as indicated, at a density of approx. (1−2) × 10
6 cells/ml.
Western blot analysis
Protein expression and phosphorylation was assessed using
standard Western blotting protocols. Brieﬂy, cell lysates (2 × 10
7
cells or 100 μg of tissue per ml of lysis buffer) were prepared on
iceusingNP-40(NonidetP40)lysisbuffer(50 mMHepes,pH 7.4,
75 mM NaCl, 1% NP-40, 10 mM NaF, 10 mM iodoacetimide,
1 mMEDTA,40 mM2-glycerophosphate,proteaseinhibitorsand
1 mM PMSF) and then centrifuged at 16000 g for 10 min at 4◦C.
Protein samples (0.25−0.5 million cell equivalents or 40 μgo f
tissue extract) were separated by SDS/PAGE (8% or 4−12%
gels), transferred on to PVDF membranes and blocked with 5%
(w/v)non-fatdriedskimmedmilkpowderinPBS/Tween20.Blots
were probed with antibodies recognizing various phosphorylated
and non-phosphorylated (total) proteins, as indicated.
Immunoprecipitation and in vitro kinase assays
Endogenous PKD isoforms were immunoprecipitated from cell
lysates with either a PKD1/2-cross-reacting antibody [33] or
with a PKD3-speciﬁc antibody [34] and recovered with Protein
A−Sepharose beads. Exogenous substrate phosphorylation
by immunoprecipitated PKD proteins was measured by the
incorporation of [γ-
32P]ATP into a synthetic PKD substrate
peptide (KKLNRTLSVA), as described previously [34].
Flow cytometry
Unless otherwise stated, antibodies conjugated to FITC,
PE (phycoerythrin), PE−Cy5.5 (indodicarbocyanine), PE−Cy7
(indotricarbocyanine) or APC (allophycocyanin) were from BD
PharmingenoreBioscience.Cellswerestainedforthecell-surface
expression of the following antigens (clones are in parentheses):
CD4 (RM4-5), CD8 (53-6.7), TCR-β (H57-597), B220 (RA3-
6B2), IgD (11-26) and IgM (11/41). DN (double-negative) and
DP (double-positive) thymocytes were deﬁned by CD8 and CD4
staining. Mature SP (single-positive) thymocytes were deﬁned as
TCRβ
Hi andpositiveforCD4orCD8expression.Whererequired,
Fc receptors were blocked with mouse Fc block (CD16/CD32;
FcγIII/II receptor; 2.4G2) (BD Pharmingen). Cells were stained
with saturating concentrations of antibody in accordance with the
manufacturer’s instructions and were washed and resuspended in
RPMI1640mediumcontaining1%FBSbeforeacquisition.Live
cellsweregatedaccordingtotheirforwardscatterandsidescatter.
Data were acquired on a FACSCalibur (Becton Dickinson) ﬂow
cytometer and analysed using FlowJo software (Treestar).
Cytokine ELISA
Lymphnodeswereharvestedanddisaggregated.CD4
+ andCD8
+
T-cells were puriﬁed by negative selection using CD4+ TC e l l
Isolation Kit or CD8+ T Cell Isolation Kit (Miltenyi Biotec)
by magnetic cell sorting (AutoMacs, Miltenyi Biotec). Cells
were stimulated with different amounts of anti-CD3ε (clone
2C11). After 18 h, supernatants were collected and cytokine
[IFNγ (interferon γ) and IL-2 (interleukin 2)] production
was determined by ELISA using Mouse IFNγ ‘Femto-HS’-
ELISA Ready-Set-Go and Mouse IL2-ELISA Ready-Set-Go kits
(eBiosciences), according to the manufacturer’s instructions.
Immunization and Ig ELISA
Sex- and age-matched mice at 8−12 weeks of age were
immunized subcutaneously with 100 μg of NP (4-hydroxy-3-
nitrophenyl acetyl)-OVA (Biosearch Technologies) pre-adsorbed
toaluminiumhydroxide(Pierce).Serawerecollectedafter0,8,14
and 29 days. Total and NP-speciﬁc Ig levels were determined by
standardELISAusingplate-boundanti-mouseIg(heavyandlight
chain) or NP−BSA33 and isotype-speciﬁc alkaline phosphatase-
conjugated goat anti-mouse antibodies (SouthernBiotech). The
reaction was revealed with pNPP (p-nitrophenyl phosphate)
(Sigma), followed by absorbance reading at 405 nm. Puriﬁed Ig
isotype standards were used to quantify speciﬁc Ig levels.
Statistical analysis
Statistical analyses were performed using GraphPad Prism 5.00
for Macintosh (GraphPad Software). P< 0.05 was considered to
be statistically signiﬁcant.
RESULTS
PKD1, but not PKD2, plays an important role in murine
embryogenesis
PKD serine kinases are large proteins comprising multiple
interaction domains, including both protein−protein- and
protein−lipid-binding regions, and have the potential to function
asscaffolds.ToexplorethephysiologicalroleofPKD2invivo,we
therefore decided to produce mice where wild-type PKD2 alleles
were replaced with mutant alleles encoding alanine substitutions
for Ser
707 and Ser
711 in the PKD catalytic domain activation loop
region. Phosphorylation of these two serine residues is critical
for PKD2 catalytic activity [36], hence studies of PKD2
SSAA mice
allowsanassessmentoftheimportanceofPKD2catalyticactivity
in vivo while bypassing any impact of removing the scaffold
function of PKD2. Accordingly, PKD2 S707A and S711A
mutations were knocked into the wild-type Prkd2 locus in mouse
ES cells by homologous recombination. The resulting ES cells
were used to derive mice expressing PKD2
SSAA under the control
of its natural promoter (Figure 1). Previous studies have shown
that homozygous deletion of PKD1 alleles causes embryonic
lethality [24]. In striking contrast, homozygous PKD2
SSAA-
knockin mice were viable, fertile and were phenotypically
indistinguishable from their wild-type littermates (Figure 1C
and results not shown). This suggests that normal embryonic
development is not perturbed by the loss of PKD2 catalytic
function.
We considered the possibility that the small amount of residual
catalytic activity still present in the PKD2
SSAA mutant protein (see
Figure 4A) might be sufﬁcient to permit normal embryogenesis.
Therefore,tovalidateourhypothesis,wegeneratedtwoadditional
PKD mutant mouse models. The ﬁrst had wild-type PKD1
alleles replaced by mutant PKD1 alleles lacking the critical
PKC-dependent serine phosphorylation sites, Ser
744 and Ser
748
(Figure 2A). We also generated PKD2-deﬁcient mice (PKD2
GT
mice) using an ES cell line containing a gene-trap cassette
inserted into the Prkd2 locus (Figure 2C). Our DNA sequence
analysis of this ES cell line conﬁrmed that the cell line contained
only a single gene-trap cassette, located within the PKD2 locus.
We mapped the gene-trap insertion site to intron 15, which
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Figure 1 Generation of mice with a knockin PKD2 mutation
(A) Depiction of the endogenousmouse Prkd2 allele containing exons 10−18, the knockin construct and the targeted allele with the neomycin cassette removed by Cre recombinase. The black/grey
rectangles represent exons and the black arrowheads represent LoxP sites. Thick black lines indicate the positions of the probes used for Southern blot analysis. The knockin allele containing the
Ser707/Ser711 mutation in exon 16 is illustrated as a grey rectangle. (B) Genotypes of PKD2SSAA mutant mice were determined by PCR ampliﬁcation of genomic DNA. The wild-type allele generates
a 236bp product, whereas the knockin allele generates a 344bp product. The larger knockin allele product is due to the presence of the 108bp LoxP site and ﬂanking region, which remains in an
intronic region following Cre-mediated excision of the neomycin-selection cassette. (C) Heterozygous matings for PKD2SSAA mice were set up and the progeny were genotyped as described in the
Materials and methods section. The number (and percentage) of each genotype observed followed by its expected Mendelian frequency. P =0.482 (χ2 test).
disruptsandeliminatesthecatalyticdomainofPKD2(Figure2C).
Importantly, PKD2
GT/GT mice were born at the normal expected
frequency (Figure 2E) and were viable, fertile and phenotypically
indistinguishable from their wild-type littermates. In contrast,
when heterozygous PKD1
SSAA mice were inter-crossed, wild-
type and heterozygous newborn mice, but not homozygous
PKD1
SSAA mice, were easily identiﬁed (Figure 2E). Of the 177
observedlivebirths,twomicewerehomozygousforthePKD1
SSAA
allele (∼1%). This indicates that homozygous expression of
the PKD1
SSAA allele causes embryonic lethality with incomplete
penetrance. This is consistent with the report by Olson and
colleagues that deletion of exons 12−14 of PKD1, which
eliminates the PKD1 catalytic domain, also causes embryonic
lethality with incomplete penetrance [24]. Analysis of the stage
of embryogenesis that required PKD1 catalytic activity revealed
that normal Mendelian frequencies of homozygous PKD1
SSAA
fetuses could be identiﬁed before day 9.5 of embryogenesis,
but not later (Figure 2E). Hence the majority of embryos with
homozygous substitutions for PKD1
SSAA alleles perish early in
development. Collectively, these results demonstrate that the
catalytic activity of PKD1, but not PKD2, is essential for normal
mouse embryogenesis.
PKD1 and PKD2 expression patterns in adult mice
Analysis of EST (expressed sequence tag)/gene expression
databases indicates that many adult tissues show co-expression of
differentPKDisoformsatthemRNAlevel(Figure3A).However,
the relative expression of speciﬁc PKD isoforms at the protein
level in different tissues and cells is not well deﬁned. In the
context of PKD1 and PKD2, which are highly homologous, most
antibodies generated against these kinases cannot discriminate
between the two isoforms. For example, the most commonly used
‘pan’-PKD antisera used to detect PKD1 in variety of tissues
was raised against the peptide sequence EEREMKALSERVSIL
(corresponding to amino acids 904−918 in murine PKD1), but
reacts equally well with PKD2. In SDS/PAGE analysis, it is
theoretically possible to discriminate PKD1 and PKD2 on the
basis of subtle differences in their electrophoretic mobility [10].
However, because the electrophoretic mobility of PKD isoforms
can be altered by protein phosphorylation [37], it is not possible
to use differential migration on SDS/PAGE gels as a reliable
criterion to distinguish PKD1 from PKD2 expression.
In this respect, the exons encoding the region of the protein
recognized by the pan-PKD antisera will not be expressed in
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Figure 2 Generation of PKD2 gene-trap mutant mice and PKD1-knockin mutant mice
(A) Depiction of the endogenous mouse Prkd1 allele containing exons 15−17, the knockin construct and the targeted allele with the neomycin cassette removed by Cre recombinase. The white/grey
rectangles represent exons and the black arrowheads represent LoxP sites. Thick black lines indicate the positions of the probes used for Southern blot analysis. The knockin allele containing the
Ser744/Ser748 mutation in exon 16 is illustrated as a grey rectangle. (B) PKD1SSAA-knockin mice were genotyped by PCR-ampliﬁcation of genomic DNA over the LoxP insertion site as described in
the Materials and methods section. (C) Depiction of the wild-type Prkd2 allele and the gene-trap-targeted Prkd2 allele present in the E14Tg2a.4 ES cell line. This insertion disrupts the catalytic
domain structure and deletes several key motifs that are important for catalysis and substrate binding (the DFG and APE motifs) as well as the Ser707 and Ser711 phosphorylation sites that are
important for PKD2 activation. (D) PKD2GT mice were genotyped by PCR ampliﬁcation of genomic DNA as described in the Materials and methods section. (E) Heterozygous matings for PKD2GT
mice and for PKD1SSAA mice were set up, and the live progeny and PKD1SSAA-knockin embryos were genotyped as described in the Materials and methods section. The number (and percentage) of
each genotype observed is shown, followed by its expected Mendelian frequency. The data were analysed using a χ2 test to determine statistical signiﬁcance.
PKD2
GT/GT mice.Accordingly,Westernblotanalysiswiththepan-
PKDantiseraoftissuesfromwild-typecomparedwithPKD2
GT/GT
mice will allow an assessment of which adult tissues express
PKD1 and PKD2. Western blot analysis of lymphoid tissue
extracts from PKD2
GT/GT mice, notably the thymus (Figure 3B),
lymph nodes and spleen (Figure 3C), reveal that these tissues do
not contain any protein reactive with the pan-PKD1/2 antisera,
indicating that T- and B-lymphocytes, which comprise the
majority of cells within these tissues, speciﬁcally express PKD2,
butnotPKD1.Incontrast,deletionofPKD2causeslittleornoloss
of total PKD1/2 protein in the brain or the pancreas, but reduces
overall PKD1/2 proteins levels in heart and kidney (Figure 3C).
Hence PKD1 and PKD2 are co-expressed in many adult tissues,
albeit at differing levels, but one exception is in lymphoid cells,
which appear to only express PKD2.
PKD2 is the major PKD isoform expressed in murine lymphocytes
The data suggesting that PKD2, but not PKD1, is selectively
expressed in lymphoid cells in adult mice were conﬁrmed
by in vitro kinase assays, comparing total PKD1/2 catalytic
activity in wild-type and PKD2
GT/GT thymocytes. Substantial
peptide substrate phosphorylation was detected in PKD1/2
immunoprecipitates prepared from phorbol-ester-activated wild-
type thymocytes, but not in those prepared from PKD2
GT/GT
thymocytes (Figure 4A). Another well-characterized marker of
endogenousPKD1/PKD2catalyticactivityisthephosphorylation
status of a conserved C-terminal autophosphorylation site (Ser
916
in PKD1; Ser
873 in PKD2). As shown in Figure 4(B), phorbol-
ester-activated wild-type, but not PKD2
GT/GT, thymocytes contain
active autophosphorylated PKD1/2 proteins.
We also examined total PKD1/2 catalytic activity in
the PKD2
SSAA-knockin lymphocytes. There was no loss
of PKD2 protein expression in homozygous PKD2
SSAA
lymphocytes, but total PKD1/2 catalytic activity was severely
impaired, as assessed by in vitro kinase assays of PKD2
proteinsimmunoprecipitatedfromphorbol-ester-stimulatedwild-
type compared with PKD2
SSAA/SSAA thymocytes (Figure 4A).
Moreover, PKD2
SSAA mutant proteins could not effectively
autophosphorylate on Ser
873 in response to phorbol ester
stimulation (Figure 4B). We did, however, detect a small amount
of residual PKD1/2 catalytic activity in activated PKD2
SSAA/SSAA
thymocytes compared with PKD2
GT/GT thymocytes. As lymphoid
cells do not express PKD1 (see above), low levels of PKD2
catalytic activity can apparently be induced in PKD2
SSAA mutant
thymocytes independently of PKC-mediated phosphorylation of
the PKD2 catalytic domain.
Strikingly, we observed that, although phorbol ester treatment
induced signiﬁcant PKD activation loop phosphorylation in
wild-type lymphocytes, this was undetectable in whole-cell
extracts prepared from phorbol-ester-stimulated PKD2
SSAA/SSAA
or PKD2
GT/GT lymphocytes, despite normal induction of ERK1/2
(extracellular-signal-regulated kinase 1/2) phosphorylation
c   The Authors Journal compilation c   2010 Biochemical Society © 2010 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.158 S. A. Matthews and others
Figure 3 Differential expression of PKD1 and PKD2 isoforms in adult tissues
(A) Prkd1, Prkd2 and Prkd3 gene expression analysis in adult murine tissues. mRNA expression data in the GeneAtlas MOE430 (gcrma) data set was downloaded from the BioGPS gene portal hub
(http://www.biogps.gnf.org)andexpressedasthefoldchangeinexpressionintheindicatedtissues,comparedwiththatexpressedinNIH3T3cells. (B)WesternblotanalysisofPKD1,PKD2andAkt
expression in wild-type compared with PKD2GT/GT thymocytes. Blots are representative of three or more separate experiments. Molecular masses are indicated in kDa. (C) Western blot analysis of
PKD1, PKD2 and Akt expression in wild-type compared with PKD2GT/GT adult tissues. Blots are from two separate PKD2SSAA/SSAA mice and their wild-type littermates. Closed arrows indicate PKD2;
open arrows indicate PKD1.
(Figure 4C). This was surprising as PKD3 is expressed in
mammalianlymphocytes[34](Figure4E)andthePKDactivation
loop segment is fully conserved in all three mammalian
PKD isoforms. Hence PKD ‘activation loop’ phospho-speciﬁc
antibodiesshouldcross-reactequallywithPKD1(phosphorylated
on Ser
744/Ser
748), PKD2 (phosphorylated on Ser
707/Ser
711)a n d
PKD3 (phosphorylated on Ser
730/Ser
734). To clarify whether the
PKD activation loop phospho-speciﬁc antibody could indeed
detect active phosphorylated PKD3 proteins, we analysed avian
DT40 B-lymphocytes, which are known to express PKD3 and
PKD1 at approximately equimolar levels, but which do not
express PKD2 [4]. The data in Figure 4(D) show that deletion
of PKD1 in DT40 B-lymphocytes results in a complete loss of
PKD1 Ser
916 phosphorylation, but only a 2−3-fold reduction in
total PKD activation loop phosphorylation levels, after phorbol
ester stimulation. Similarly, in PKD3
−/− DT40 cells, there was
no change in PKD1 Ser
916 phosphorylation and again only a
2−3-fold reduction in PKD activation loop phosphorylation
levels after phorbol ester stimulation (Figure 4D). Thus PKD
activation loop phospho-speciﬁc antibodies can very efﬁciently
detect active phosphorylated PKD3 in cells that express high
PKD3proteinlevels.Indeed,whenweimmunoprecipitatedPKD3
proteins from phorbol-ester-activated PKD2
GT/GT thymocytes, we
were now able to detect PKD3 activation loop phosphorylation
(Figure4E).Accordingly,thefailuretodetectanyPKDactivation
loop phosphorylation in whole-cell extracts prepared from PKD2
mutant lymphocytes argues that PKD3 does not make a large
quantitative contribution to the total PKD protein pool in murine
lymphoid cells/tissues.
Although PKD3 protein expression is very low in murine
lymphocytes, it was important to assess whether the loss of
PKD2 catalytic activity had any impact on PKD3 expression
or activity. We therefore immunoprecipitated PKD3 from
control and phorbol-ester-stimulated wild-type and PKD2 mutant
thymocytes.Intheseexperiments,wefoundthatPKD3expression
levels and catalytic activity were normal in wild-type, PKD2
GT/GT
and PKD2
SSAA/SSAA thymocytes (Figure 4F). Thus the loss of
PKD2 expression and or catalytic activity in lymphoid cells is
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Figure 4 PKD2 is the dominant PKD isoform expressed in murine lymphoid tissue and cells
(A) Global PKD1/2 catalytic activity in wild-type and PKD2 mutant thymocytes. PKD1/2 proteins were immunoprecipitated from phorbol-ester-activated thymocytes using pan-PKD1/2 antisera [33]
before PKD catalytic activity was measured in in vitro peptide substrate kinases assays, as described in the Materials and methods section. Data are from eight wild-type, eight PKD2GT/GT and six
PKD2SSAA/SSAA thymi, assayed in three separate experiments. Results are means + S.E.M.; statistical signiﬁcance was calculated by a Student’s t test. (B) PKD1/2 autophosphorylation on Ser916 and
Ser873 respectively in whole-cell extracts prepared from control and phorbol-ester-activated wild-type, heterozygous and homozygous PKD2GT and PKD2SSAA thymocytes. Blots are representative of
two independent experiments. (C) Analysis of PKD activation loop and ERK1/2 phosphorylation in whole-cell extracts prepared from wild-type, PKD2GT/GT and PKD2SSAA/SSAA splenocytes activated
with phorbol ester for 15min. Similar results were observed in phorbol-ester-activated thymocytes. (D) PKD activation loop and Ser916 phosphorylation in wild-type, PKD1−/− and PKD3−/− DT40
B-cells activated with phorbol ester for 15min. (E) Analysis of PKD activation loop phosphorylation in PKD3 immunoprecipitates prepared from untreated and phorbol-ester-activated wild-type
and PKD2GT/GT thymocytes. (F) PKD3 expression and catalytic activity in primary wild-type and homozygous PKD2GT and PKD2SSAA lymphoid cells. PKD3 proteins were immunoprecipitated from
phorbol-ester-activated thymocytes using a speciﬁc anti-PKD3 antibody [34] before PKD3 catalytic activity was measured in in vitro peptide substrate kinases assays, as described in the Materials
andmethodssection.Resultsarefromfourtosixwild-type,PKD2GT/GT andPKD2SSAA/SSAA thymi,assayedinthreeseparateexperimentsandaremeans+S.E.M.Student’st testwasusedtocalculate
statistical signiﬁcance.
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not compensated for by increased expression/activity of other
PKD isoforms. Nor is there any evidence that expression of a
catalytically inactive PKD2 has any dominant-negative effect on
PKD3 expression or activity.
PKD2 is dispensable for the development of mature T-lymphocytes
Since PKD2 is the major PKD isoform expressed in the
thymus and in mature T-lymphocytes (results not shown), we
asked whether PKD2 catalytic function is essential for normal
T-lymphocyte development. Previous studies have shown that
PKD can be activated by the pre-TCR in T-cell progenitors in
the thymus and by the mature α/β TCR complex in peripheral
T-cells[30,33].Todate,experimentsexploringtheconsequenceof
PKD activity for TCR function have used transgenesis techniques
to target an activated PKD mutant protein (comprising the
catalytic domain of PKD1) to either to the membrane or cytosol
of pre-T-cells. These experiments demonstrate that constitutively
active PKD signalling can substitute for the pre-TCR to drive
T-cell proliferation and differentiation in recombinase-gene-null
mice [30]. However, experiments with such gain-of-function
mutants can inform about the functional capacity of a protein
kinase, but they do not assess whether the kinase is essential for
a particular biological process.
We therefore investigated T-cell development in PKD2
GT/GT
and PKD2
SSAA/SSAA mice using ﬂow cytometry to deﬁne the
major thymic and peripheral T-cell subpopulations. Early
T-lymphocyte progenitors in the thymus are DN for the MHC
co-receptors CD4 and CD8. These DN progenitors undergo
TCRβ locus rearrangements to produce a TCRβ polypeptide that
permits cell-surface expression of the pre-TCR complex. The
pre-TCR then supports the survival and rapid clonal expansion of
DN progenitors along with their differentiation into CD4
+CD8
+
DP thymocytes. TCRα chain gene rearrangements then occur,
and cells that express a functional, but non-self-reactive, α/β
TCR complex differentiate into either CD4
+ or CD8
+ SP
T-lymphocytes. Thymi from PKD2
SSAA/SSAA and PKD2
GT/GT mice
did not display any obvious abnormalities and contained normal
numbers of DN, DP and mature SP thymocytes that express
high levels of the mature α/β TCR complex (Figures 5A
and 5B). Moreover, these mature SP thymocytes were able
to exit the thymus and populate peripheral tissues normally,
since the frequencies and total numbers of peripheral CD4
+
and CD8
+ T-lymphocytes in the lymph nodes and spleen of
wild-type, PKD2
SSAA/SSAA and PKD2
GT/GT mice were comparable
(Figures 5C and 5D, and results not shown). Similarly,
B-lymphocyte development within the bone marrow occurred
normally in the absence of PKD2 catalytic activity (results not
shown), resulting in normal total numbers of mature IgM/IgD-
expressing B-lymphocytes in the spleens and lymph nodes of
PKD2
SSAA/SSAA and PKD2
GT/GT mice (Figures 5C and 5D, and
results not shown). Thus PKD2 kinase activity is dispensable
for the normal development of mature, peripheral T- and
B-lymphocytes.
PKD2 catalytic activity is important for mature peripheral
T-lymphocytes
The next question addressed was whether or not PKD2 has
any role in peripheral T-cells. As shown in Figure 6(A), TCR
engagement induces robust and sustained phosphorylation of
PKD2 on Ser
707/Ser
711, and correspondingly increases PKD2
catalytic activity, resulting in increased autophosphorylation on
Ser
873. It is well established that phosphorylation of Ser
707/Ser
711
within the PKD2 catalytic domain is mediated by PKCs [36].
In this context, PKC isoforms that have been implicated in
the regulation of PKD activation loop phosphorylation and
activationinresponsetoantigenreceptorligationincludePKCδ in
B-lymphocytes [38] and a redundant role for PKCα and PKCθ
in T-lymphocytes (G. Baier, personal communication). It is also
known that PKC enzymes have a key role in T-lymphocytes
to control expression of cytokine genes in TCR-triggered cells
[39−41].IthasalsobeenreportedthatPKD2canactivatereporter
constructs for the cytokine IL-2 in the leukaemic Jurkat T-cell
line [42]. We therefore asked whether PKD2 catalytic activity is
required to support normal lymphocyte activation responses.
We initially compared the proliferative responses of wild-
type and PKD2
SSAA/SSAA lymphocytes. However, we observed
no major differences in the proliferative capability of mutant
PKD2 lymphocytes compared with wild-type controls after
in vitro stimulation of the TCR (results not shown). However,
it was striking that the ability of both CD4
+ and CD8
+ T-
cells to produce the effector cytokines IL-2 and IFNγ was
severelyattenuatedinPKD2
SSAA/SSAA T-lymphocytesthathadbeen
stimulated in vitro via the TCR (Figure 6B). Thus PKD2 catalytic
activityisrequiredforefﬁcientantigenreceptor-inducedcytokine
production in mature peripheral T-lymphocytes.
We explored further the in vivo function of PKD2 catalytic
activitybylookingattheabilityofPKD2mutantmicetomountan
immune response to a model antigen. We immunized control
and PKD2
SSAA/SSAA mice with NP-OVA, an antigen that elicits
antibody production in a T-cell-dependent fashion. At different
time points after immunization, the serum levels of antigen-
speciﬁcIgsweredeterminedbyELISA.AsshowninFigure7(A),
baseline serum Ig titres were normal in PKD2
SSAA/SSAA mice.
However, PKD2
SSAA/SSAA mice showed reduced antigen-speciﬁc
IgM and IgG1 responses compared with those of wild-type mice
(Figure7B).ThusPKD2catalyticactivityisimportantforoptimal
T-cell-dependent antibody responses in vivo.
DISCUSSION
ToexploretheroleofPKD1andPKD2invivo,wehavegenerated
mice in which wild-type PKD1 and PKD2 alleles were replaced
with mutants with alanine substitutions for Ser
744/Ser
748 and
Ser
707/Ser
711 respectively. These serine residues are located within
the PKD catalytic domains, and in vitro studies have shown
that they are phosphorylated by classical/novel PKC isoforms,
thereby activating PKD catalytic activity [36,43]. The importance
of these phosphorylation events for PKD regulation in vivo was
not known. However, the inability of the PKD1
SSAA/SSAA mutant
to support embryo development now shows that phosphoryation
of Ser
744/Ser
748 is essential for PKD1 function in vivo. The data
also show that PKD1 and PKD2 isoforms have unique functions
in vivo: loss of PKD1 expression [24] or catalytic function (the
present study) results in early embryonic lethality. In contrast,
the loss of PKD2 expression or catalytic function in vivo has no
impact on normal embryonic development. Moreover, adult mice
in which wild-type PKD2 alleles are deleted or replaced with
catalytically inactive PKD2 mutants are viable and fertile.
A major aim of the present study was to explore whether there
is any unique role for PKD2 in vivo. A striking ﬁnding in the
present study is our discovery that PKD2 is the major PKD
isoform expressed in murine T- and B-lymphocytes; PKD1 is not
expressed in these cells, whereas PKD3 is apparently expressed
only at very low levels in primary murine lymphoid cells.
Moreover, PKD2 catalytic activity was important for effector
cytokine production after TCR engagement. PKD2 was also
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Figure 5 PKD2 is dispensable for development of mature T- and B-lymphocytes
Expression of CD4/CD8 DP and SP subsets in thymi from wild-type compared with PKD2GT/GT (A) or wild-type compared with PKD2SSAA/SSAA mice (B). Analysis of peripheral T-cell (TCRβ+CD4+
and TCRβ+CD8+) and B-cell (B220+IgMlo/+IgDlo/+) subsets in spleens from wild-type compared with PKD2GT/GT (C) or wild-type compared with PKD2SSAA/SSAA mice (D). Tissues from the PKD2
mutant mice and wild-type littermate controls were harvested at 8−12weeks, stained with speciﬁc antibodies and analysed by ﬂow cytometry as described in the Materials and methods section.
Results are means + S.E.M. (n  7 mice).
important for optimal induction of antibody responses to a model
antigen. PKD2 thus has a unique role in adult mice to control the
function of lymphoid cells.
PKDs are highly conserved enzymes, but the evolution of
multiple isoforms seems to be associated with evolution
of vertebrates, hence amphibians, ﬁsh and birds express two
PKD isoforms, whereas mammals express three PKD family
members. The invertebrate PKD found in Drosophila is most
closely homologous with the mammalian PKD3 isoform; the
second PKD isoform found in ﬁsh and amphibians most closely
resembles PKD1; in contrast, PKD2 appears to have evolved
with mammals. The present data show that there is differential
expression of PKD isoforms in different tissues, in particular the
unique expression of PKD2 in primary and secondary lymphoid
tissues. Exactly what cellular mechanisms control the differential
expression levels of different PKD isoforms in different tissues
and at different stages of development remains unclear. Why
lymphocytes would express PKD2 rather than PKD1 when they
have shared substrate speciﬁcities and are regulated by identical
intracellular signalling mechanisms is also unclear. Nevertheless,
the failure of T-cells to express PKD1 allows PKD2 to have a
unique non-redundant role in T-cells to mediate TCR-induced
production of the essential cytokines IL-2 and IFNγ.
The induction of IL-2 and IFNγ production in response to
TCR engagement is mediated by DAG signalling pathways and
PKCs, notably PKCα and PKCθ [39−41]. In vitro studies have
alsoshownthatseveraldifferentPKCisoformscanphosphorylate
Ser
707 and Ser
711 in PKD2, thereby activating the kinase [36], but
theimportanceofthispathwayforPKDregulationinvivowasnot
previously known. The failure of PKD2
SSAA/SSAA T-lymphocytes
to effectively produce IL-2 and IFNγ thus reveals that PKD
functions downstream of PKCs to control cytokine production
in T-cells. The cytokines IL-2 and IFNγ play a critical role in
adaptive immune responses and the present study thus also
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Figure 6 PKD2 catalytic activity is important for peripheral T-lymphocyte function
(A)CD8+ na¨ ıveT-cellswerepuriﬁedfromOTI-TCRtransgeniclymphnodecellsandstimulatedinvitro withspeciﬁcOVApeptide.Atdifferenttimepoints,cellswerelysedandproteinphosphorylation
and expression was assessed by Western blotting. (B) CD4+ and CD8+ na¨ ıve T-cells were puriﬁed separately from wild-type, PKD2SSAA/SSAA and PKD2GT/GT lymph nodes and stimulated in vitro via
the TCR for 18h with increasing concentrations of an anti-CD3ε monoclonal antibody. IL-2 and IFNγ levels in the culture supernatant were determined by ELISA. Results are means + S.E.M. for
triplicate samples and are representative of two separate experiments.
Figure 7 PKD2 catalytic activity is important for efﬁcient humoral immune
responses against T-cell-dependent antigens
(A) ELISA of basal serum Ig levels in control and PKD2SSAA-knockin mice. Results are
means+ −S.E.M. (n=4 mice per genotype). (B) PKD2SSAA/SSAA and PKD2WT/WT mice were
immunized with NP-OVA on day 0. Serum anti-NP IgM and IgG1 levels were determined
on days 8, 14 and 29 after immunization by ELISA of serial dilutions of serum. Results are
means+ −S.E.M. (n=4 mice per genotype). Statistical signiﬁcance was calculated by two-way
ANOVA.P =0.001andP =0.081forNP-speciﬁcIgMandNP-speciﬁcIgG1 levelsrespectively.
Results are representative of two independent experiments.
provides evidence that PKD2 has a unique non-redundant role
to control T-cell functions during adaptive immune responses.
A role for PKD2 in mammalian adaptive immune responses is
intriguing because DKF-2, a Caenorhabditis elegans PKD acts
downstream of DAG and PKCs to regulate innate immunity in
the nematode [44]. The participation of PKDs in the mechanisms
that control immune responses is therefore a conserved one.
In summary, our in vivo data conﬁrm the functional importance
of the PKC-mediated serine phosphorylation sites located within
the PKD catalytic domain for PKD1 and PKD2 activation and
downstream signalling. They also provide further evidence that
PKDisoformsmayactasdownstreameffectorsofDAG-regulated
PKC enzymes in vivo.
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